| MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy S Elad, KKF Cheng, RV Lalla, N Yarom, C Hong, RM Logan, J Bowen, ... Cancer 126 (19), 4423-4431, 2020 | 514 | 2020 |
| Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer M Srivastava, N Brito-Dellan, MP Davis, M Leach, R Lagman Journal of pain and symptom management 25 (6), 578-582, 2003 | 139 | 2003 |
| Opioid and adjuvant analgesics: compared and contrasted MIA Khan, D Walsh, N Brito-Dellan American Journal of Hospice and Palliative Medicine® 28 (5), 378-383, 2011 | 105 | 2011 |
| Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines DP Saunders, T Rouleau, K Cheng, N Yarom, A Kandwal, J Joy, ... Supportive Care in Cancer 28, 2473-2484, 2020 | 80 | 2020 |
| Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents CP Escalante, YC Chang, K Liao, T Rouleau, J Halm, P Bossi, ... Supportive Care in Cancer 24, 4057-4074, 2016 | 26 | 2016 |
| Thrombosis, cancer, and COVID-19 N Brito-Dellan, N Tsoukalas, C Font Supportive Care in Cancer 30 (10), 8491-8500, 2022 | 25 | 2022 |
| Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: Challenging issues in the care of patients regarding cancer-associated thrombosis (CAT) N Tsoukalas, N Brito-Dellan, C Font, T Butler, CM Rojas-Hernandez, ... Supportive Care in Cancer 30 (10), 8559-8573, 2022 | 24 | 2022 |
| Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care JC Laguna, T Cooksley, S Ahn, N Tsoukalas, TH Oo, N Brito-Dellan, ... Supportive Care in Cancer 30 (10), 8577-8588, 2022 | 17 | 2022 |
| Handoff Tool Enabling Standardized Transitions Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center CE Gonzalez, N Brito-Dellan, SR Banala, D Rubio, M Ait Aiss, TW Rice, ... American Journal of Medical Quality, 1062860618776096, 2018 | 16 | 2018 |
| Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies C Font, MG de Herreros, N Tsoukalas, N Brito-Dellan, F Espósito, ... Supportive Care in Cancer 30 (10), 8599-8609, 2022 | 14 | 2022 |
| Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative review K Dickson, K Koom-Dadzie, N Brito-Dellan, C Escalante Supportive Care in Cancer 30 (10), 8539-8545, 2022 | 7 | 2022 |
| Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm N Brito-Dellan, MC Franco-Vega, JI Ruiz, M Lu, H Sahar, P Rajapakse, ... Supportive Care in Cancer 32 (10), 661, 2024 | 2 | 2024 |
| Safer transitions of care at a major cancer center: The emergency center to hospitalist experience. S Banala, CE Gonzalez, N Brito-Dellan, D Rubio, M Ait Aiss, T Rice, ... Journal of Clinical Oncology 34 (7_suppl), 247-247, 2016 | 2 | 2016 |
| Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study RJ Chan, R Knowles, FD Ashbury, J Bowen, A Chan, M Chin, I Olver, ... EClinicalMedicine 76, 2024 | 1 | 2024 |
| Improving transitions of care through implementation of a standardized handoff at a comprehensive cancer center. DC Bodurka, M Ait Aiss, HP Phu, LR Day, V Abraham, K Chen, M Rodrigo, ... Journal of Clinical Oncology 34 (7_suppl), 242-242, 2016 | 1 | 2016 |
| 1182 Multisystem immunotherapy-related adverse events among patients with breast cancer treated with immune checkpoint inhibitors AB Pillai, N Sadiq, R Chua, AA Tijani, HE Tierce, CS Clavijo, A Agu, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
| Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study R Abdalla-Aslan, P Bonomo, D Keefe, N Blijlevens, K Cao, YT Cheung, ... EClinicalMedicine 73, 2024 | | 2024 |
| Treatment patterns and outcomes of high-grade immune checkpoint inhibitor-related pneumonitis in an oncology hospitalist service JGM Manzano, H Sahar, J Aldrich, M Lu, M Shoukier, CB Peterson, ... Supportive Care in Cancer 32 (3), 160, 2024 | | 2024 |
| Improving the care of patients with lung cancer hospitalized with immune checkpoint inhibitor-related pneumonitis: Implementation of a clinical pathway algorithm. JGM Manzano, MC Franco-Vega, JI Ruiz, M Lu, HN Sahar, ... Journal of Clinical Oncology 41 (16_suppl), e18730-e18730, 2023 | | 2023 |
| Immune checkpoint inhibitor (ICI)-related pneumonitis among patients with lung cancer admitted to an Oncology Hospitalist Service: Treatment patterns and hospitalization outcomes. HN Sahar, J Aldrich, CB Peterson, N Brito-Dellan, M Lu, M Shoukier, ... Journal of Clinical Oncology 39 (15_suppl), e21054-e21054, 2021 | | 2021 |
